Novan Therapeutics' Series D - III Round

Novan Therapeutics raised a round of funding on December 17, 2015.

Novan is a clinical-stage drug development company aiming to commercialize nitric oxide-based products in selected therapeutic areas. The Company's core technologies solve the delivery issues with nit…

Articles about Novan Therapeutics' Series D - III Round: